Cartesian Therapeutics's total assets for Q3 2025 were $372.68M, a decrease of -4.17% from the previous quarter. RNAC total liabilities were $408.52M for the fiscal quarter, a 4.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.